These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15013932

  • 1. Pimecrolimus for the treatment of inflammatory skin disease.
    Wolff K, Stuetz A.
    Expert Opin Pharmacother; 2004 Mar; 5(3):643-55. PubMed ID: 15013932
    [Abstract] [Full Text] [Related]

  • 2. Pimecrolimus: a review.
    Gupta AK, Chow M.
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):493-503. PubMed ID: 12941081
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K, Jarvis B.
    Drugs; 2002 Sep; 62(5):817-40. PubMed ID: 11929333
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity.
    Stuetz A, Grassberger M, Meingassner JG.
    Semin Cutan Med Surg; 2001 Dec; 20(4):233-41. PubMed ID: 11770910
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.
    Kapp A, Papp K, Bingham A, Fölster-Holst R, Ortonne JP, Potter PC, Gulliver W, Paul C, Molloy S, Barbier N, Thurston M, de Prost Y, Flare Reduction in Eczema with Elidel (infants) multicenter investigator study group.
    J Allergy Clin Immunol; 2002 Aug; 110(2):277-84. PubMed ID: 12170269
    [Abstract] [Full Text] [Related]

  • 11. Pimecrolimus: a review of its use in atopic dermatitis.
    Wellington K, Noble S.
    Am J Clin Dermatol; 2004 Aug; 5(6):479-95. PubMed ID: 15663345
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pimecrolimus: a review of pre-clinical and clinical data.
    Graham-Brown RA, Grassberger M.
    Int J Clin Pract; 2003 May; 57(4):319-27. PubMed ID: 12800465
    [Abstract] [Full Text] [Related]

  • 14. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis.
    Reitamo S, Remitz A, Kyllönen H, Saarikko J.
    Am J Clin Dermatol; 2002 May; 3(6):381-8. PubMed ID: 12113647
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR.
    Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
    [Abstract] [Full Text] [Related]

  • 17. Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated.
    Rappersberger K, Komar M, Ebelin ME, Scott G, Burtin P, Greig G, Kehren J, Chibout SD, Cordier A, Holter W, Richter L, Oberbauer R, Stuetz A, Wolff K.
    J Invest Dermatol; 2002 Oct; 119(4):876-87. PubMed ID: 12406334
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pimecrolimus 1% cream for the treatment of atopic dermatitis.
    Wolff K.
    Skin Therapy Lett; 2005 Oct; 10(8):1-6. PubMed ID: 16292456
    [Abstract] [Full Text] [Related]

  • 20. Atopic dermatitis: a new treatment paradigm using pimecrolimus.
    Weinberg JM, Bowerman JG, Brown SM, Gerstein D, Kane KS, Selevan J, Virdee S.
    J Drugs Dermatol; 2003 Apr; 2(2):131-40. PubMed ID: 12852364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.